1. Home
  2. AIMD vs TNON Comparison

AIMD vs TNON Comparison

Compare AIMD & TNON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AIMD

Ainos Inc.

HOLD

Current Price

$1.55

Market Cap

10.6M

Sector

Health Care

ML Signal

HOLD

Logo Tenon Medical Inc.

TNON

Tenon Medical Inc.

HOLD

Current Price

$0.82

Market Cap

9.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AIMD
TNON
Founded
1984
2012
Country
United States
United States
Employees
N/A
27
Industry
Biotechnology: Pharmaceutical Preparations
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.6M
9.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
AIMD
TNON
Price
$1.55
$0.82
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$3.00
AVG Volume (30 Days)
85.2K
1.1M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$19.56
Revenue Next Year
N/A
$71.06
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.43
$0.64
52 Week High
$4.50
$5.85

Technical Indicators

Market Signals
Indicator
AIMD
TNON
Relative Strength Index (RSI) 44.39 44.18
Support Level $1.26 $0.64
Resistance Level $1.98 $1.18
Average True Range (ATR) 0.15 0.07
MACD 0.02 0.02
Stochastic Oscillator 46.38 55.05

Price Performance

Historical Comparison
AIMD
TNON

About AIMD Ainos Inc.

Ainos Inc is a dual-platform AI and biotech company pioneering smelltech and immune therapeutics. Its AI Nose platform and smell language model (SLM) digitize scent into Smell ID, a machine-readable data format, powering intelligent sensing across robotics, smart factories, and healthcare. The company also develops VELDONA, a low-dose oral interferon targeting rare, autoimmune, and infectious diseases. It combines AI and Nose, redefining machine perception for the sensory age.

About TNON Tenon Medical Inc.

Tenon Medical Inc is a medical device company that has developed a novel, minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.

Share on Social Networks: